Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited logo

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14)

Market Open
7 Aug, 09:00
SGX SGX
$
2. 75
+0.01
+0.365%
$
- Market Cap
- P/E Ratio
0.6% Div Yield
170,700 Volume
- Eps
$ 2.74
Previous Close
Add Transaction
Day Range
2.71 2.76
Year Range
2.48 3.75
Want to track T14 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

T14 trading today higher at $2.75, an increase of 0.365% from yesterday's close, completing a monthly decrease of -1.0791% or -$0.03. Over the past 12 months, T14 stock lost -19.3548%.
T14 pays dividends to its shareholders, with the most recent payment made on Jul 10, 2026. The next estimated payment will be in In 4 months on Jan 10, 2027 for a total of $0.34446.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has completed 1 stock splits, with the recent split occurring on Jun 30, 2010.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on SSE (CNY).

T14 Chart

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14) FAQ

What is the stock price today?

The current price is $2.75.

On which exchange is it traded?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is listed on SGX.

What is its stock symbol?

The ticker symbol is T14.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, no market cap data is available.

Has Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited ever had a stock split?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited had 1 splits and the recent split was on Jun 30, 2010.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Lei Wang CEO
SGX Exchange
CNE100000924 ISIN
China Country
4,619 Employees
12 Feb 2026 Last Dividend
5 Jul 2010 Last Split
- IPO Date

Overview

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, a comprehensive entity that encompasses a wide array of activities within the pharmaceutical industry, marks its presence predominantly within the People’s Republic of China. The company’s operations span across the production and distribution of traditional Chinese medicine (TCM) and Western medicine, reflecting a synergistic blend of ancient practices and modern pharmacology. Established in 1981 and rooted in Tianjin, this conglomerate has expanded its portfolio to include chemical raw materials, pharmaceutical preparations, and biomedical products, thereby catering to a broad spectrum of healthcare needs. In May 2022, it underwent a significant rebranding from its former identity as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, indicating a strategic pivot or expansion in its business model. Besides its manufacturing prowess, the company is also actively involved in the wholesale and retail sectors of the medicine market, alongside offering pharmaceutical commercial logistic services.

Products and Services

  • Suxiao Jiuxin Pills: A renowned traditional Chinese medicine product designed for the treatment of heart-related ailments.

  • Jingwanhong Ointment: This ointment is used primarily for its healing properties in treating burns, wounds, and skin ulcers.

  • Biqi Capsules: Aimed at alleviating pain and discomfort associated with rheumatism and arthritis.

  • Shunaoxin Dropping Pills: Developed to enhance cardiovascular health, these pills address cerebrovascular conditions.

  • Zilongjin Tablets: These tablets are used in the management of various cancer conditions, supporting traditional cancer treatments.

  • Qingfei Xiaoyan Pills: Intended for respiratory conditions, these pills help in clearing heat and detoxifying the lungs.

  • Huoxiangzhengqi Soft Capsules: Used primarily for gastrointestinal discomfort, these capsules aid in digestion and relieve symptoms of food poisoning.

  • Tongmai Yangxin Pills: Targets cardiovascular diseases, promoting heart health and improving circulation.

  • Weichangan Pills: These pills are focused on improving gastrointestinal health and function.

  • Qingyan Dropping Pills: Designed for throat health, these pills relieve sore throat and hoarseness.

  • Haima Bushen Pills: Focused on kidney health, these pills are used in traditional treatments for enhancing vitality and energy.

  • Angong Niuhuang Pills: A critical care TCM product, used in treatments of high fever, convulsions, and strokes.

  • Niuhuang Qingxin Pills: Similar to Angong Niuhuang Pills, these are used for heart and brain health, particularly in acute conditions.

  • Qinggong Shoutao Pills: Aimed at promoting longevity and enhancing overall wellness, based on TCM principles.

In addition to the aforementioned pharmaceutical products, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited delves into commercial logistics services within the pharmaceutical realm. This encompasses a comprehensive suite of offerings aimed at optimizing the supply chain and distribution channels for pharmaceuticals, thus ensuring efficient and timely delivery of medical products. Additionally, the company’s involvement in chemical raw materials and preparations, along with biomedicine, broadens its scope and capacity to contribute significantly to the health sector, both nationally and potentially internationally.

Contact Information

Address: Darentang Building
Phone: 86 22 2702 0598